---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-122229"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:28:24.579673+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q3 revenue $28.7M, net loss $0.55/share; raises FY2024 revenue guidance to ~$112M

## Summary
- Revenue $28.7M down 6% YoY but up 5% QoQ; product revenue $20.3M down 14% YoY.
- Recurring revenue (cartridges + service) $21M, up 17% YoY; gross margin 34.3% vs 23.6% YoY.
- Net loss $27.9M ($0.55/share) vs $46.2M ($0.93/share) in Q3 2023; non-GAAP net loss $20.2M ($0.39/share).
- FY2024 revenue guidance raised to ~$112M from ~$110M; non-GAAP gross margin guided to mid-30% range.
- Cash & investments $179.0M as of Sept 30, 2024; operating expenses down 36% YoY.

## SEC filing metadata
- accession: 0000950170-24-122229
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017024122229/0000950170-24-122229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017024122229/om-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-122229
- JSON: https://secwatch.observer/filing/0000950170-24-122229.json
- Plain text: https://secwatch.observer/filing/0000950170-24-122229.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.